-The Times of India NEW DELHI: New medicines for treatment of diabetes, hypertension and pneumonia are set to be cheaper from Diwali. Drug price regulator National Pharmaceutical Pricing Authority (NPPA) has capped prices of as many as 18 new brands of essential medicines, most of which are expected to be launched in the market within a fortnight. The regulator has brought these medicines under price regulation using paragraph 5 of the Drugs...
More »SEARCH RESULT
Health ministry against task force proposal to hike prices of vital drugs -Sushmi Dey
-The Times of India NEW DELHI: A government task force has recommended changes in the existing drug price regulation which could result in a spike in prices of essential medicines. These include suggestions to pull several medicines out of price control, which is likely to impact drugs used in treatment of diabetes, cancer and cardiovascular diseases as well as antibiotics. "There is a need to review the implementation of DPCO (Drugs Price...
More »Drug pricing policy irrational, re-examine it, Supreme Court tells Centre
-The Times of India NEW DELHI: The Supreme Court on Wednesday asked the Centre to re-examine its drug pricing policy for essential medicines, calling it "unreasonable and irrational" as the price of some medicines is at around 4000% higher than what has been fixed by some state governments. A bench headed by Justice TS Thakur asked the ministry of chemicals and fertilizers to analyze and give explanation why the controlled price of...
More »No Medicine for the Common ‘Jan’ -Archana Mishra
-Tehelka The NDA government’s move to open more Jan Aushadhi stores ignores the multitude of issues currently plaguing them Amidst the jostling crowd at the Guru Teg Bahadur Hospital in Shahdara, Delhi, is 68-year-old Suresh Chandra, holding his medical files on one hand and prescription letter on the other. Chandra, who is a lung disease patient, moves towards the Jan Aushadhi store, situated in the hospital premises. Chandra hopes that the government-run medical...
More »Chemists will have to mention in bill whether drug is price controlled -Sushmi Dey
-The Times of India NEW DELHI: In an attempt to empower consumers and save them from paying more for medicines, the government is set to make it mandatory for chemists to mention in the bill whether they are selling a price-controlled product or not. Besides, the bill will also mention the price of the medicine as capped by the government. The move will enable a consumer to make an informed choice while...
More »